Business
-
Pearl Therapeutics has won a 2012 TiE50 award from the Indus Entrepreneurs (TiE). Pearl was one of ten winners in the life sciences category. Pearl develops inhaled therapies based on its proprietary particle engineering technology.… Read more . . .
-
The US Patent and Trade Office has awarded a second patent, to Aegis Therapeutics for stabilized formulations of parathyroid hormone and parathyroid hormone analogs. The new patent (US Patent No. 8,173,594) covers formulations for both… Read more . . .
-
Rigel Pharmaceuticals says that it plans to focus its efforts on two inhaled asthma therapies: R343, an inhaled SYK inhibitor and R256, an inhaled IL13 signaling/JAK inhibitor. A Phase 2 clinical study of R343 will… Read more . . .
-
Inhaler testing equipment company Copley Scientific has entered into distribution agreements with companies in Turkey and Brazil and now has a Chinese sales and technical support representative in Nanjing, China. Copley sells a range of… Read more . . .
-
Texas-based biotechnology company Pulmotect has been granted an award of $7.1 million by the Cancer Prevention & Research Institute of Texas (CPRIT) for development of its lead product PUL-042, an inhaled immune stimulant composed of… Read more . . .
-
The non-profit patient education organization Allergy & Asthma Network Mothers of Asthmatics (AANMA) has announced the winners of its 2012 Top Ten Innovations in Technology Awards for “products and services that have meaningfully improved quality… Read more . . .
-
Sunovion has announced that it will make its Zetonna ciclesonide nasal aerosol for the treatment of allergic rhinitis available in the US in time for the fall allergy season. The FDA approved Zetonna, an HFA… Read more . . .
-
A review paper published in the Spring 2012 issue of European Respiratory Disease contends that, “Drug delivery to lungs with a consistent and predesigned ratio of co-associated active components can help maximise the chance of… Read more . . .
-
The FDA issued a drug shortage alert for the Asmanex Twisthaler 110 mcg mometasone furoate inhalation Powder, 30 inhalation units, as of April 26, 2012. According to the FDA web site, the shortage is due… Read more . . .
-
SK Biopharmaceuticals has licensed its diazepam nasal spray for an undisclosed amount to Seoul, Korea-based Hanmi Pharmaceuticals, giving Hanmi marketing rights for China and Korea. Hanmi expects to launch the nasal spray in Korea in… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden